Ranolazine alleviates contrast-associated acute kidney injury through modulation of calcium independent oxidative stress and apoptosis
Authors:
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 267, 118920
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 32 references indexed in Scilit:
- Ranolazine recruits muscle microvasculature and enhances insulin action in ratsThe Journal of Physiology, 2013
- Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium SensitivityCirculation Research, 2012
- Endothelial Cells Derived From Human iPSCS Increase Capillary Density and Improve Perfusion in a Mouse Model of Peripheral Arterial DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Reactive Oxygen Species and the Pathogenesis of Radiocontrast-Induced NephropathyInvestigative Radiology, 2010
- α2-Adrenergic agonists protect against radiocontrast-induced nephropathy in miceAmerican Journal of Physiology-Renal Physiology, 2008
- Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts — Role of late sodium current and intracellular ion accumulationJournal of Molecular and Cellular Cardiology, 2008
- Ischemia/Reperfusion Induce Renal Tubule Apoptosis by Inositol 1,4,5-Trisphosphate Receptor and L-Type Ca2+ Channel OpeningAmerican Journal of Nephrology, 2008
- RanolazineNature Reviews Drug Discovery, 2006
- Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJACC, 2004
- Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failureJournal of Cardiac Failure, 2002